As a clinic seeing many patients from Germany, I share my observations:

• In Germany, HSG is not performed; instead, hysterosonography is used. If tubes are blocked, typically there’s no intervention. In Turkey, HSG is routine, and if there’s hydrosalpinx we remove the tube because it reduces embryo implantation potential.
• In Germany, if there’s no known genetic risk, PGT is not usually allowed. In Turkey, however, PGT is applied in cases of advanced maternal age, recurrent miscarriages, or to shorten infertility duration.
• In Germany, follow-up visits are more infrequent; on the day of ovulation trigger, the size of the follicles is less emphasized. In Turkey, more frequent monitoring is done, especially in women with low ovarian reserve.
• In Germany, embryo transfer is commonly done on day 2 or 3 and strict single embryo transfer limits are enforced. In Turkey, day-5 (blastocyst) transfer is commonly done, and in suitable cases, two embryos may be transferred.
• In Germany, non–evidence-based adjunct support therapies (e.g., IVIG, intralipid) are rarely used. In Turkey, these supports are more widely applied in repeated implantation failure cases.
• Success rates in Turkey can reach up to 70%. Drug costs may be similar to Germany, but total treatment costs are generally more favorable in Turkey.

If you have questions about IVF treatment in Turkey, feel free to contact us.